JUN 02, 2022 8:00 AM PDT

Human vs. AI: Why manual curation is irreplaceable in clinical genomics

Sponsored by: QIAGEN
Speaker

Abstract
Date:  June 02, 2022
Time: 8:00am (PDT),  11:00am (EDT), 5:00pm (CEST)
 
Artificial intelligence (AI) is currently a buzzword across almost all scientific disciplines and has the potential to revolutionize diagnostic approaches in inherited diseases. But when it comes to variant curation, is AI capable of replacing human expertise? A new study by Stanford University compares data quality from their Automatic VAriant evidence DAtabase (AVADA) to the Human Gene Mutation Database (HGMD).
 
The results show that expert curation by variant scientists is irreplaceable in the field of clinical genomics, with HGMD recovering nearly 40% more disease-associated mutations than the AI-powered AVADA.
 
In this webinar, we demonstrate the depth and breadth of HGMD through a series of use-cases where the manually curated database outperforms AI solutions, including how HGMD:
 
  • Provides genomic coordinates and Human Genome Variation Society (HGVS) nomenclature for variants as well as citations and comments for key publications
  • Indicates where a variant is described in a paper or supplemental text
  • Enables database entries to be visualized via tools, such as IGV and UCSC Genome Browser
  • Simplifies literature review with legacy/alternative variant naming schemes
  • Supports CNV interpretation and “reverse” look-up by phenotype
 
 
In addition, all webinar attendees will receive a complimentary, 5-day trial of HGMD Professional.
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
MAY 19, 2022 8:00 AM PDT
MAY 19, 2022 8:00 AM PDT
Date: May 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Mass spectrometry (MS)-based proteomic technologies are increasingly applied in a clinical context for disease classific...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
MAR 29, 2022 9:00 AM PDT
C.E. CREDITS
MAR 29, 2022 9:00 AM PDT
Date: March 29, 2022 Time: 09:00am (PDT), 12:00pm (EDT), 17:00 (GMT) Advances in molecular and immunodiagnostics are enabling a personalized, high-precision approach to health in many clin...
Loading Comments...
Show Resources
Event Countdown
  • 0 Days
  • 0 Hours
  • 0 Minutes
  • 0 Seconds